Reed Elizabeth E (CIK 0001283303)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: Chief Legal Officer and GC
Shares held
10,000
Last filed at
Sep 24, 2025
Confidence Score
44.8
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 22, 2025 Sep 24, 2025 Travere Therapeutics, Inc. Chief Legal Officer and GC Sell 22.5 -10,000 -10.01% ✓ $250K
May 2, 2025 May 5, 2025 Travere Therapeutics, Inc. Chief Legal Officer and GC Sell 32.5 -4,920 -5.21% ✓ $103.6K
Feb 10, 2025 Feb 12, 2025 Travere Therapeutics, Inc. SVP, GC & CORPORATE SECRETARY Sell 28.8 -8,000 -8.21% ✓ $188.2K
Jan 31, 2025 Feb 4, 2025 Travere Therapeutics, Inc. SVP, GC & CORPORATE SECRETARY Sell 95.0 +12,549 16.31% ✓ $177.1K
Jan 22, 2025 Jan 23, 2025 Travere Therapeutics, Inc. SVP, GC & CORPORATE SECRETARY Sell 41.3 -2,437 -3.07% ✓ $47.4K
Sep 5, 2024 Sep 9, 2024 Travere Therapeutics, Inc. SVP, GC & CORPORATE SECRETARY Sell 87.5 +2,363 3.10% ✓ $50.5K
Jan 31, 2024 Feb 2, 2024 Travere Therapeutics, Inc. SVP, GC & CORPORATE SECRETARY Sell 91.3 +20,236 36.11% ✓ $41.5K
Jan 23, 2024 Jan 25, 2024 Travere Therapeutics, Inc. SVP, GC & CORPORATE SECRETARY Sell 41.3 -2,062 -3.55% ✓ $18.5K
Aug 31, 2023 Sep 5, 2023 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 83.8 +1,485 2.62% ✓ $26.7K
May 10, 2023 May 12, 2023 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 48.8 -825 -1.44% ✓ $13.7K
Jan 31, 2023 Feb 2, 2023 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 95.0 +17,660 44.40% ✓ $57.6K
Jan 24, 2023 Jan 26, 2023 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 41.3 -2,062 -4.93% ✓ $44.3K
May 10, 2022 May 12, 2022 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 41.3 -1,950 -4.45% ✓ $41.9K
Jan 31, 2022 Feb 2, 2022 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 91.3 +8,490 24.05% ✓ $37K
Jan 24, 2022 Jan 26, 2022 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 32.5 -2,250 -5.99% ✓ $56.2K
Jan 10, 2022 Jan 12, 2022 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 53.8 - 0.00% ✓ $137K
Aug 13, 2021 Aug 17, 2021 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 86.3 +3,093 8.98% ✗ $24.1K
May 11, 2021 May 13, 2021 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 28.8 -3,250 -8.62% ✓ $62.7K
Feb 5, 2021 Feb 9, 2021 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 25.0 -4,500 -10.66% ✓ $141.7K
Feb 3, 2021 Feb 3, 2021 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 28.8 -3,175 -7.77% ✓ $91.8K
Jan 31, 2021 Feb 2, 2021 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 87.5 +1,825 4.67% ✓ $97.6K
Jan 5, 2021 Jan 7, 2021 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 36.3 -1,376 -5.41% ✓ $36.9K
Nov 16, 2020 Nov 17, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 28.8 -2,500 -8.95% ✓ $60K
Nov 11, 2020 Nov 13, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 90.0 +2,500 9.83% ✓ $59K
Sep 23, 2020 Sep 23, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 36.3 -1,500 -5.57% ✓ $27.7K
Sep 18, 2020 Sep 22, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 86.3 +1,500 5.90% ✓ $27.9K
May 11, 2020 May 13, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 36.3 -1,577 -5.84% ✓ $25.8K
Mar 10, 2020 Mar 12, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 25.0 -3,500 -11.47% ✓ $52.6K
Jan 7, 2020 Jan 8, 2020 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 32.5 -1,500 -7.69% ✓ $21.8K
May 14, 2019 May 16, 2019 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 36.3 -1,050 -5.11% ✓ $18.6K
Feb 11, 2019 Feb 13, 2019 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 28.8 -1,769 -10.83% ✓ $37.9K
Jan 8, 2019 Jan 9, 2019 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 32.5 -1,500 -8.41% ✓ $35.9K
Nov 14, 2018 Nov 16, 2018 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 15.0 -5,000 -21.90% ✓ $120.1K
Jan 5, 2018 Jan 8, 2018 Travere Therapeutics, Inc. SVP, GC & Corporate Secretary Sell 26.3 -942 -9.42% ✗ $22.6K